1.
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
by Carhart-Harris, R. L
Psychopharmacology, 2017-11-08, Vol.235 (2), p.399-408
2.
Helicobacter pylori treatment in the era of increasing antibiotic resistance
by Graham, David Y
Gut, 2010-08, Vol.59 (8), p.1143-1153
3.
Pulsed radiofrequency treatment in interventional pain management: mechanisms and potential indications-a review
by Chua Hai Liang, N
Acta neurochirurgica, 2011, Vol.153 (4), p.763-771
4.
Advanced Oxidation Processes in Water/Wastewater Treatment: Principles and Applications. A Review
by Oturan, Mehmet A.
Critical reviews in environmental science and technology, 2014-12-02, Vol.44 (23), p.2577-2641
5.
Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study
by Arriola-Villalobos, Pedro
British journal of ophthalmology, 2012-05, Vol.96 (5), p.645-649
6.
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
by Schweickert, William D, MD
The Lancet (British edition), 2009, Vol.373 (9678), p.1874-1882
7.
Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial
by Klazen, Caroline AH, Dr
The Lancet (British edition), 2010, Vol.376 (9746), p.1085-1092
8.
Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled tria...
by Wiles, Nicola, Dr
The Lancet (British edition), 2013, Vol.381 (9864), p.375-384
9.
Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
by Stroud, J. B
Psychopharmacology, 2017-10-30, Vol.235 (2), p.459-466
10.
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial
by Mendelow, A David, Prof
The Lancet (British edition), 2013, Vol.382 (9890), p.397-408
11.
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
by White, PD, Prof
The Lancet (British edition), 2011, Vol.377 (9768), p.823-836
12.
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
by Ochs-Ross, Rachel
The American journal of geriatric psychiatry, 2020-02, Vol.28 (2), p.121-141
13.
A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
by Eisendrath, Stuart J
Psychotherapy and psychosomatics, 2016-01-01, Vol.85 (2), p.99-110
14.
Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder
by Lecavalier, Luc
Journal of autism and developmental disorders, 2013-10-26, Vol.44 (5), p.1128-1143
15.
Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs
by Finlay, Andrea K
Journal of studies on alcohol and drugs, 2018-11, Vol.79 (6), p.909-917
16.
Randomized Controlled Trial: Multimodal Anxiety and Social Skill Intervention for Adolescents with Autism Spectrum Disorder
by White, Susan W
Journal of autism and developmental disorders, 2012-06-27, Vol.43 (2), p.382-394
17.
Individualized Therapy for Persistent Asthma in Young Children
by Fitzpatrick, Anne M., Ph.D
Journal of allergy and clinical immunology, 2016, Vol.138 (6), p.1608-1618.e12
18.
Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised compa...
by Kojodjojo, Pipin
Heart (British Cardiac Society), 2010-09, Vol.96 (17), p.1379-1384
19.
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection...
by Lawitz, Eric, Prof
The Lancet (British edition), 2015, Vol.385 (9973), p.1075-1086
20.
Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States
by Abraham, Amanda J
Journal of studies on alcohol and drugs, 2013-03, Vol.74 (2), p.258-265
